You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BRAFV600E/K mutation

Showing 1 - 25 of 6,763
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Melanoma Trial in New York (Dabrafenib)

Completed
Has Results
  • Melanoma
  • New York, New York
    Memorial Sloan Kettering Cancer Center
May 8, 2020

Unresectable or Metastatic BRAFV600E Mutant Melanoma Patients

Recruiting
  • Melanoma (Skin)
  • +2 more
    • Evora, Portugal
      Hospital Evora
    May 30, 2022

    Metastatic Colorectal Cancer, BRAF V600E Mutation Positive Trial in France (Collection of blood samples)

    Not yet recruiting
    • Metastatic Colorectal Cancer
    • BRAF V600E Mutation Positive
    • Collection of blood samples
    • Avignon, France
    • +26 more
    Nov 25, 2022

    Pediatric Recurrent/Refractory BRAFV600E-mutant Gliomas Trial in Canada, United States (Vemurafenib)

    Active, not recruiting
    • Pediatric Recurrent/Refractory BRAFV600E-mutant Gliomas
    • Los Angeles, California
    • +20 more
    Jan 4, 2023

    Metastatic Radioactive Iodine Refractory Thyroid Cancer Patients With RAS or BRAF Mutation Trial in Villejuif (Trametinib,

    Active, not recruiting
    • Metastatic Radioactive Iodine Refractory Thyroid Cancer Patients With RAS or BRAF Mutation
    • Villejuif, Val De Marne, France
      Gustave Roussy
    Sep 27, 2021

    Aspirin in Combination With Trametinib and Dabrafenib

    Not yet recruiting
    • NSCLC
    • +4 more
    • Combind asprin with Trametinib and Dabrafenib
    • (no location specified)
    Aug 4, 2023

    First Line Treatment for BRAFV600E Mutant Metastatic Colorectal

    Completed
    • BRAF V600E Mutation Positive
    • Metastatic Colorectal Cancer
    • Non Interventional study
    • St. Veit/Glan, Austria
    • +33 more
    Jan 20, 2023

    Dabrafenib Plus Trametinib In Rare BRAF V600E Mutation-Positive

    Not yet recruiting
    • Rare Unresectable or Metastatic BRAF V600E Mutation-positive Solid Tumors
    • Non-investigational
    • (no location specified)
    May 11, 2023

    Melanoma Trial in Beijing (HL-085, Vemurafenib)

    Recruiting
    • Melanoma
    • Beijing, Beijing, China
      Beijing Cancer Hospital
    Apr 10, 2022

    Cancer Trial (Dabrafenib, Trametinib)

    Not yet recruiting
    • Cancer
    • (no location specified)
    May 25, 2023

    BRAF V600E Mutation Trial run by the NHGRI (Dabrafenib Mesylate, Trametinib Dimethyl Sulfoxide)

    Completed
    Has Results
    • BRAF V600E Mutation
    • Dabrafenib Mesylate
    • Trametinib Dimethyl Sulfoxide
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 6, 2021

    Colorectal Cancer, BRAF V600E Mutation Positive Trial (Encorafenib Oral Capsule + Cetuximab)

    Not yet recruiting
    • Colorectal Cancer
    • BRAF V600E Mutation Positive
    • Encorafenib Oral Capsule + Cetuximab
    • (no location specified)
    Jan 30, 2023

    Non Small Cell Lung Cancer Trial (HLX208+HLX10)

    Not yet recruiting
    • Non Small Cell Lung Cancer
    • HLX208+HLX10
    • (no location specified)
    Nov 30, 2022

    Differentiated Thyroid Cancer Trial in Worldwide (Dabrafenib, Trametinib, Trametinib )

    Recruiting
    • Differentiated Thyroid Cancer
    • Caba, Buenos Aires, Argentina
    • +41 more
    Nov 25, 2022

    BRAF V600E-mutant Metastatic Non-small Cell Lung Cancer

    Recruiting
    • Metastatic Non-small Cell Lung Cancer
    • BRAF V600 Mutation
      • Lyon, Rhône Alpes, France
        CHU Lyon - Hôpital Cardio-Vasculaire et Pneumologique Louis Prad
      Sep 14, 2022

      Malignant Melanoma, BRAF V600 Mutation, Brain Metastases Trial in France (Stereotaxic radiosurgery (SRS), Binimetinib Oral

      Recruiting
      • Malignant Melanoma
      • +2 more
      • Stereotaxic radiosurgery (SRS)
      • +3 more
      • Bobigny, France
      • +20 more
      Oct 7, 2022

      Melanoma Trial in Boston, Harrison, New York (Dabrafenib, Trametinib, Phenformin)

      Active, not recruiting
      • Melanoma
      • Boston, Massachusetts
      • +2 more
      Jun 14, 2022

      NSCLC, Non-small Cell Carcinoma, Histiocytic Tumor Trial (BDTX-4933)

      Not yet recruiting
      • Non-small Cell Lung Cancer
      • +32 more
      • (no location specified)
      Mar 30, 2023

      Metastatic Colorectal Cancer, mCRC Trial in Shenyang (HLX208)

      Recruiting
      • Metastatic Colorectal Cancer
      • mCRC
      • Shenyang, Liaoning, China
        Liaoning Cancer Hospital
      May 1, 2022

      Metastatic Colorectal Cancer Trial in Boston (Dabrafenib, Trametinib, PDR001)

      Recruiting
      • Metastatic Colorectal Cancer
      • Boston, Massachusetts
      • +1 more
      Jun 24, 2022

      Stratification of Overlap Syndrome Phenotype in E1784K Mutation

      Recruiting
      • Long QT Syndrome
      • +3 more
        • Saint-Pierre, France, Réunion
          CHU de La Réunion
        Oct 19, 2022

        Colorectal Cancer, Colon Cancer, BRAF V600E Trial (Binimetinib)

        Not yet recruiting
        • Colorectal Cancer
        • +4 more
        • (no location specified)
        Aug 18, 2022

        Pathologic Stage IIIB Cutaneous Melanoma AJCC v8, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8, Pathologic Stage IIID

        Active, not recruiting
        • Pathologic Stage IIIB Cutaneous Melanoma AJCC v8
        • +2 more
        • Houston, Texas
          M D Anderson Cancer Center
        Aug 9, 2022

        Melanoma Metastatic, BRAF V600 Mutation Trial in Italy (Experimental combination beyond Focal Progression, Pembrolizumab or

        Active, not recruiting
        • Melanoma Metastatic
        • BRAF V600 Mutation
        • Experimental combination beyond Focal Progression
        • Pembrolizumab or Nivolumab
        • Bari, BA, Italy
        • +13 more
        Dec 1, 2021

        BRAF NP_004324.2:p.V600E, BRAF V600K Mutation Present, Thyroid Gland Anaplastic Carcinoma Trial in Duarte, Columbus (Dabrafenib,

        Recruiting
        • BRAF NP_004324.2:p.V600E
        • +2 more
        • Duarte, California
        • +1 more
        Jan 19, 2023